NFKB1 and rheumatoid arthritis: Likewise, miR-410-3p reduces inflammation in RA by inhibiting the NF-κB pathway, leading to decreased levels of pro-inflammatory cytokines like TNF-α, IL-1β, IL-6, and MMP-9 (91).